Synopsys Other Non-Current Liabilities decreased by 2.2% to $1.61B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 225.4%, from $495.69M to $1.61B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 42.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $343.66M | $355.45M | $391.43M | $380.14M | $345.77M | $352.19M | $327.83M | $364.98M | $365.95M | $389.52M | $381.53M | $436.53M | $446.51M | $465.23M | $469.74M | $495.69M | $488.58M | $1.80B | $1.65B | $1.61B |
| QoQ Change | — | +3.4% | +10.1% | -2.9% | -9.0% | +1.9% | -6.9% | +11.3% | +0.3% | +6.4% | -2.0% | +14.4% | +2.3% | +4.2% | +1.0% | +5.5% | -1.4% | +267.9% | -8.3% | -2.2% |
| YoY Change | — | — | — | — | +0.6% | -0.9% | -16.2% | -4.0% | +5.8% | +10.6% | +16.4% | +19.6% | +22.0% | +19.4% | +23.1% | +13.6% | +9.4% | +286.4% | +251.1% | +225.4% |